How much money can be saved by applying intravenous antibiotics once instead of several times a day?

Infection

Volumn 38, Issue 6, 2010, Pages 479-482

  Mertz, D ^a   Plagge, H ^a   Bassetti, S ^a,b   Battegay, M ^a   Widmer, A F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Kantonsspital Olten ^*  (Switzerland)

Author keywords

Administration; Antibiotics; Cost saving; Indirect costs; Once daily

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CILASTATIN PLUS IMIPENEM; ERTAPENEM; FLUCLOXACILLIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DISPOSABLE EQUIPMENT; DOSAGE SCHEDULE COMPARISON; DRUG COST; HEALTH CARE COST; HUMAN; NURSE; SALARY; WORKING TIME; WORKLOAD;

ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; HUMANS; INFUSIONS, INTRAVENOUS; SWITZERLAND;

EID: 78651288983     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0060-x     Document Type: Article

References (10)

1. AR van Zanten PM Engelfriet K van Dillen M van Veen MJ Nuijten KH Polderman 2003 Importance of nondrug costs of intravenous antibiotic therapy Crit Care 7 R184 R190 10.1186/cc2388 14624694
2. E Flynn A Marciniak G Barbabietola BA Oppenheim C Roberts K Barker 2009 A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole J Clin Nurs 18 1168 1179 10.1111/j.1365-2702.2008.02512.x 19017372
3. D Mertz M Koller P Haller ML Lampert H Plagge B Hug G Koch M Battegay U Flückiger S Bassetti 2009 Outcomes of early switching from intravenous to oral antibiotics on medical wards J Antimicrob Chemother 64 188 199 1:CAS:528:DC%2BD1MXntlGgsLc%3D 10.1093/jac/dkp131 19401304
4. AD Tice RS Turpin CT Hoey BA Lipsky J Wu MA Abramson 2007 Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections Am J Health Syst Pharm 64 1080 1086 17494908
5. PG Clay MR Graham CC Lindsey KC Lamp C Freeman A Glaros 2004 Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males Am J Geriatr Pharmacother 2 181 189 1:CAS:528:DC%2BD2cXhtVKnt7rI 10.1016/j.amjopharm.2004.09.006 15561650 (Pubitemid 39618443)
6. AD Tice PA Hoaglund B Nolet PS McKinnon E Mozaffari 2002 Cost perspectives for outpatient intravenous antimicrobial therapy Pharmacotherapy 22 63S 70S 10.1592/phco.22.4.63S.33653 11837549
7. AD Tice 2004 Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy J Antimicrob Chemother 53 ii83 ii86 1:CAS:528: DC%2BD2cXlvF2msr4%3D 10.1093/jac/dkh210 15150187
8. V Wirtz K Taxis ND Barber 2003 An observational study of intravenous medication errors in the United Kingdom and in Germany Pharm World Sci 25 104 111 10.1023/A:1024009000113 12840963 (Pubitemid 36749801)
9. KN Barker EA Flynn GA Pepper DW Bates RL Mikeal 2002 Medication errors observed in 36 health care facilities Arch Intern Med 162 1897 1903 10.1001/archinte.162.16.1897 12196090
10. LA Mermel M Allon E Bouza DE Craven P Flynn NP O'Grady II Raad BJ Rijnders RJ Sherertz DK Warren 2009 Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America Clin Infect Dis 49 1 45 1:CAS:528:DC%2BD1MXovVCnsro%3D 10.1086/599376 19489710